| Literature DB >> 20937561 |
Dong Wook Kang1, Yong Soo Kim, Kwang Su Lim, Myeong Seop Kim, Larry V Pearce, Vladimir A Pavlyukovets, Andy K Tao, Krystle A Lang-Kuhs, Peter M Blumberg, Jeewoo Lee.
Abstract
As an extension of our analysis of the effect of halogenation on thiourea TRPV1 agonists, we have now modified selected 4-hydroxy(or 4-amino)-3-methoxyphenyl acetamide TRPV1 agonists by 5- or 6-halogenation on the aromatic A-region and evaluated them for potency for TRPV1 binding and regulation and for their pattern of agonism/antagonism (efficacy). Halogenation shifted the functional activity at TRPV1 toward antagonism with a greater extent of antagonism as the size of the halogen increased (I>Br>Cl), as previously observed for the thiourea series. The extent of antagonism was greater for halogenation at the 5-position than at the 6-position, in contrast to SAR for the thiourea series. In this series, compounds 55 and 75 showed the most potent antagonism, with K(i) (ant)=2.77 and 2.19nM, respectively, on rTRPV1 expressed in Chinese hamster ovary cells. The compounds were thus ca. 40-60-fold more potent than 6'-iodononivamide.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20937561 PMCID: PMC3420354 DOI: 10.1016/j.bmc.2010.09.001
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641